| D6V | Name: | 2-[(3S)-pyrrolidin-3-yl]-1H-benzimidazole | Formula: | C11 H13 N3 | SMILES: | c32nc(C1CNCC1)nc2cccc3 | InChi: | InChI=1S/C11H13N3/c1-2-4-10-9(3-1)13-11(14-10)8-5-6-12-7-8/h1-4,8,12H,5-7H2,(H,13,14)/t8-/m0/s1 | Definition date: | 2017-10-20 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | 2-[(3S)-pyrrolidin-3-yl]-1H-benzimidazole |
|
| D6Y | Name: | 3-[(5-tert-butyl-1,2-oxazol-3-yl)methyl]oxetan-3-amine | Formula: | C11 H18 N2 O2 | SMILES: | c1(onc(c1)CC2(N)COC2)C(C)(C)C | InChi: | InChI=1S/C11H18N2O2/c1-10(2,3)9-4-8(13-15-9)5-11(12)6-14-7-11/h4H,5-7,12H2,1-3H3 | Definition date: | 2017-10-20 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | 3-[(5-tert-butyl-1,2-oxazol-3-yl)methyl]oxetan-3-amine |
|
| D74 | Name: | (1R,2S,3R,4R)-3-amino-4-(3-methylphenyl)cyclopentane-1,2-diol | Formula: | C12 H17 N O2 | SMILES: | c2c(C1C(C(C(C1)O)O)N)cc(cc2)C | InChi: | InChI=1S/C12H17NO2/c1-7-3-2-4-8(5-7)9-6-10(14)12(15)11(9)13/h2-5,9-12,14-15H,6,13H2,1H3/t9-,10-,11-,12-/m1/s1 | Definition date: | 2017-10-20 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | (1R,2S,3R,4R)-3-amino-4-(3-methylphenyl)cyclopentane-1,2-diol |
|
| D8A | Name: | (1R,2S,3R,4R)-3-amino-4-cyclohexylcyclopentane-1,2-diol | Formula: | C11 H21 N O2 | SMILES: | C2C(C1C(C(C(C1)O)O)N)CCCC2 | InChi: | InChI=1S/C11H21NO2/c12-10-8(6-9(13)11(10)14)7-4-2-1-3-5-7/h7-11,13-14H,1-6,12H2/t8-,9-,10-,11-/m1/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | (1R,2S,3R,4R)-3-amino-4-cyclohexylcyclopentane-1,2-diol |
|
| D8D | Name: | 1-[(1R)-1-cyclohexyl-2-(methylamino)-2-oxoethyl]-L-proline | Formula: | C14 H24 N2 O3 | SMILES: | C1C(CCCC1)C(N2C(CCC2)C(O)=O)C(=O)NC | InChi: | InChI=1S/C14H24N2O3/c1-15-13(17)12(10-6-3-2-4-7-10)16-9-5-8-11(16)14(18)19/h10-12H,2-9H2,1H3,(H,15,17)(H,18,19)/t11-,12+/m0/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | 1-[(1R)-1-cyclohexyl-2-(methylamino)-2-oxoethyl]-L-proline |
|
| D8J | Name: | 2-amino-1,4-anhydro-2,5-dideoxy-5-[(4-fluorobenzene-1-carbonyl)amino]-D-arabinitol | Formula: | C12 H15 F N2 O3 | SMILES: | c1cc(F)ccc1C(=O)NCC2C(O)C(N)CO2 | InChi: | InChI=1S/C12H15FN2O3/c13-8-3-1-7(2-4-8)12(17)15-5-10-11(16)9(14)6-18-10/h1-4,9-11,16H,5-6,14H2,(H,15,17)/t9-,10-,11+/m1/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | 2-amino-1,4-anhydro-2,5-dideoxy-5-[(4-fluorobenzene-1-carbonyl)amino]-D-arabinitol |
|
| D8M | Name: | 2-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxytetrahydrofuran-2-yl]-N-(pyridin-2-ylmethyl)acetamide | Formula: | C13 H19 N3 O4 | SMILES: | OC2C(CC(=O)NCc1ccccn1)OC(C2O)CN | InChi: | InChI=1S/C13H19N3O4/c14-6-10-13(19)12(18)9(20-10)5-11(17)16-7-8-3-1-2-4-15-8/h1-4,9-10,12-13,18-19H,5-7,14H2,(H,16,17)/t9-,10+,12-,13+/m0/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | 2-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxytetrahydrofuran-2-yl]-N-(pyridin-2-ylmethyl)acetamide (non-preferred name) |
|
| D8P | Name: | [(2S)-1,9-dimethyl-1,2,3,4,5,6-hexahydropyrido[2,3-b][1,5]diazocin-2-yl]methanol | Formula: | C12 H19 N3 O | SMILES: | c21CNCCC(N(c1nc(cc2)C)C)CO | InChi: | InChI=1S/C12H19N3O/c1-9-3-4-10-7-13-6-5-11(8-16)15(2)12(10)14-9/h3-4,11,13,16H,5-8H2,1-2H3/t11-/m0/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | [(2S)-1,9-dimethyl-1,2,3,4,5,6-hexahydropyrido[2,3-b][1,5]diazocin-2-yl]methanol |
|
| D8V | Name: | 4-(2-{[methyl(prop-2-yn-1-yl)amino]methyl}-1,3-thiazol-4-yl)piperidin-4-ol | Formula: | C13 H19 N3 O S | SMILES: | C(N(C)CC#C)c2nc(C1(CCNCC1)O)cs2 | InChi: | InChI=1S/C13H19N3OS/c1-3-8-16(2)9-12-15-11(10-18-12)13(17)4-6-14-7-5-13/h1,10,14,17H,4-9H2,2H3 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | 4-(2-{[methyl(prop-2-yn-1-yl)amino]methyl}-1,3-thiazol-4-yl)piperidin-4-ol |
|
| D97 | Name: | (1S,2S,3S,4R,5R)-4-(morpholin-4-yl)-2-[(quinolin-3-ylmethyl)amino]-6,8-dioxabicyclo[3.2.1]octan-3-ol | Formula: | C20 H25 N3 O4 | SMILES: | O5CCN(C3C4OCC(C(NCc1cc2c(nc1)cccc2)C3O)O4)CC5 | InChi: | InChI=1S/C20H25N3O4/c24-19-17(22-11-13-9-14-3-1-2-4-15(14)21-10-13)16-12-26-20(27-16)18(19)23-5-7-25-8-6-23/h1-4,9-10,16-20,22,24H,5-8,11-12H2/t16-,17-,18-,19+,20-/m1/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | (1S,2S,3S,4R,5R)-4-(morpholin-4-yl)-2-[(quinolin-3-ylmethyl)amino]-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
| D9D | Name: | (1S,2S,3S,4R,5R)-2-({[5-(hydroxymethyl)furan-2-yl]methyl}amino)-4-(morpholin-4-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol | Formula: | C16 H24 N2 O6 | SMILES: | OC2C(C3COC(C2N1CCOCC1)O3)NCc4oc(CO)cc4 | InChi: | InChI=1S/C16H24N2O6/c19-8-11-2-1-10(23-11)7-17-13-12-9-22-16(24-12)14(15(13)20)18-3-5-21-6-4-18/h1-2,12-17,19-20H,3-9H2/t12-,13-,14-,15+,16-/m1/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | (1S,2S,3S,4R,5R)-2-({[5-(hydroxymethyl)furan-2-yl]methyl}amino)-4-(morpholin-4-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
| D9M | Name: | (1S,2S,3S,4R,5R)-4-(morpholin-4-yl)-2-[(pyridin-4-ylmethyl)amino]-6,8-dioxabicyclo[3.2.1]octan-3-ol | Formula: | C16 H23 N3 O4 | SMILES: | O1CCN(CC1)C3C4OCC(C(NCc2ccncc2)C3O)O4 | InChi: | InChI=1S/C16H23N3O4/c20-15-13(18-9-11-1-3-17-4-2-11)12-10-22-16(23-12)14(15)19-5-7-21-8-6-19/h1-4,12-16,18,20H,5-10H2/t12-,13-,14-,15+,16-/m1/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | (1S,2S,3S,4R,5R)-4-(morpholin-4-yl)-2-[(pyridin-4-ylmethyl)amino]-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
| D9S | Name: | 2-{(3R,4S)-3-[(5-{[benzyl(methyl)amino]methyl}-1,2-oxazol-3-yl)methyl]piperidin-4-yl}-N-(1,3-thiazol-2-yl)acetamide | Formula: | C23 H29 N5 O2 S | SMILES: | c1cc(ccc1)CN(Cc2cc(no2)CC3CNCCC3CC(Nc4nccs4)=O)C | InChi: | InChI=1S/C23H29N5O2S/c1-28(15-17-5-3-2-4-6-17)16-21-13-20(27-30-21)11-19-14-24-8-7-18(19)12-22(29)26-23-25-9-10-31-23/h2-6,9-10,13,18-19,24H,7-8,11-12,14-16H2,1H3,(H,25,26,29)/t18-,19-/m0/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | 2-{(3R,4S)-3-[(5-{[benzyl(methyl)amino]methyl}-1,2-oxazol-3-yl)methyl]piperidin-4-yl}-N-(1,3-thiazol-2-yl)acetamide |
|
| D9V | Name: | (1S,2S,3S,4R,5R)-2-[(furan-2-ylmethyl)amino]-4-(piperidin-1-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol | Formula: | C16 H24 N2 O4 | SMILES: | OC3C(NCc1occc1)C4COC(C3N2CCCCC2)O4 | InChi: | InChI=1S/C16H24N2O4/c19-15-13(17-9-11-5-4-8-20-11)12-10-21-16(22-12)14(15)18-6-2-1-3-7-18/h4-5,8,12-17,19H,1-3,6-7,9-10H2/t12-,13-,14-,15+,16-/m1/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | (1S,2S,3S,4R,5R)-2-[(furan-2-ylmethyl)amino]-4-(piperidin-1-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
| D9Y | Name: | 1-cyclohexyl-3-[(1S,2S,3S,4R,5R)-3-hydroxy-4-(piperidin-1-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]urea | Formula: | C18 H31 N3 O4 | SMILES: | OC3C(NC(=O)NC1CCCCC1)C4COC(C3N2CCCCC2)O4 | InChi: | InChI=1S/C18H31N3O4/c22-16-14(20-18(23)19-12-7-3-1-4-8-12)13-11-24-17(25-13)15(16)21-9-5-2-6-10-21/h12-17,22H,1-11H2,(H2,19,20,23)/t13-,14-,15-,16+,17-/m1/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | 1-cyclohexyl-3-[(1S,2S,3S,4R,5R)-3-hydroxy-4-(piperidin-1-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]urea (non-preferred name) |
|
| O1H | Name: | 4-[[5-[7-chloranyl-3-(1~{H}-indazol-6-yl)benzotriazol-5-yl]pyrazol-1-yl]methyl]benzenecarbonitrile | Formula: | C24 H15 Cl N8 | SMILES: | Clc1cc(cc2n(nnc12)c3ccc4cn[nH]c4c3)c5ccnn5Cc6ccc(cc6)C#N | InChi: | InChI=1S/C24H15ClN8/c25-20-9-18(22-7-8-28-32(22)14-16-3-1-15(12-26)2-4-16)10-23-24(20)30-31-33(23)19-6-5-17-13-27-29-21(17)11-19/h1-11,13H,14H2,(H,27,29) | Definition date: | 2020-01-21 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | 4-[[5-[7-chloranyl-3-(1~{H}-indazol-6-yl)benzotriazol-5-yl]pyrazol-1-yl]methyl]benzenecarbonitrile |
|
| O1Q | Name: | 4-chloranyl-1-(1~{H}-indazol-6-yl)-6-[2-(3-methylphenyl)pyrazol-3-yl]benzotriazole | Formula: | C23 H16 Cl N7 | SMILES: | Cc1cccc(c1)n2nccc2c3cc(Cl)c4nnn(c5ccc6cn[nH]c6c5)c4c3 | InChi: | InChI=1S/C23H16ClN7/c1-14-3-2-4-17(9-14)30-21(7-8-26-30)16-10-19(24)23-22(11-16)31(29-28-23)18-6-5-15-13-25-27-20(15)12-18/h2-13H,1H3,(H,25,27) | Definition date: | 2020-01-21 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | 4-chloranyl-1-(1~{H}-indazol-6-yl)-6-[2-(3-methylphenyl)pyrazol-3-yl]benzotriazole |
|
| O1T | Name: | [[(2~{R},3~{S},4~{R},5~{R})-5-[6-chloranyl-4-[[(1~{S})-1-(4-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid | Formula: | C20 H24 Cl F N4 O9 P2 | SMILES: | C[CH](Nc1cc(Cl)nc2n(ncc12)[CH]3O[CH](CO[P](O)(=O)C[P](O)(O)=O)[CH](O)[CH]3O)c4ccc(F)cc4 | InChi: | InChI=1S/C20H24ClFN4O9P2/c1-10(11-2-4-12(22)5-3-11)24-14-6-16(21)25-19-13(14)7-23-26(19)20-18(28)17(27)15(35-20)8-34-37(32,33)9-36(29,30)31/h2-7,10,15,17-18,20,27-28H,8-9H2,1H3,(H,24,25)(H,32,33)(H2,29,30,31)/t10-,15+,17+,18+,20+/m0/s1 | Definition date: | 2020-01-21 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | [[(2~{R},3~{S},4~{R},5~{R})-5-[6-chloranyl-4-[[(1~{S})-1-(4-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid |
|
| DC7 | Name: | 4-[2-({methyl[(pyridin-3-yl)methyl]amino}methyl)-1,3-thiazol-4-yl]piperidin-4-ol | Formula: | C16 H22 N4 O S | SMILES: | c1cc(cnc1)CN(Cc3nc(C2(O)CCNCC2)cs3)C | InChi: | InChI=1S/C16H22N4OS/c1-20(10-13-3-2-6-18-9-13)11-15-19-14(12-22-15)16(21)4-7-17-8-5-16/h2-3,6,9,12,17,21H,4-5,7-8,10-11H2,1H3 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | 4-[2-({methyl[(pyridin-3-yl)methyl]amino}methyl)-1,3-thiazol-4-yl]piperidin-4-ol |
|
| O91 | Name: | [2-(4-methylphenyl)-1H-imidazol-4-yl](3,4,5-trimethoxyphenyl)methanone | Formula: | C20 H20 N2 O4 | SMILES: | c1c(OC)c(c(cc1C(=O)c2cnc(n2)c3ccc(cc3)C)OC)OC | InChi: | InChI=1S/C20H20N2O4/c1-12-5-7-13(8-6-12)20-21-11-15(22-20)18(23)14-9-16(24-2)19(26-4)17(10-14)25-3/h5-11H,1-4H3,(H,21,22) | Definition date: | 2019-06-18 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | [2-(4-methylphenyl)-1H-imidazol-4-yl](3,4,5-trimethoxyphenyl)methanone |
|
| DD4 | Name: | (3R,5R)-5-[3-(3-fluoro-4-methylphenyl)-1,2,4-oxadiazol-5-yl]pyrrolidin-3-ol | Formula: | C13 H14 F N3 O2 | SMILES: | c1(cc(F)c(C)cc1)c2noc(n2)C3NCC(C3)O | InChi: | InChI=1S/C13H14FN3O2/c1-7-2-3-8(4-10(7)14)12-16-13(19-17-12)11-5-9(18)6-15-11/h2-4,9,11,15,18H,5-6H2,1H3/t9-,11-/m1/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | (3R,5R)-5-[3-(3-fluoro-4-methylphenyl)-1,2,4-oxadiazol-5-yl]pyrrolidin-3-ol |
|
| DD7 | Name: | (1S,2S,3S,4R,5R)-2-(benzylamino)-4-(phenylsulfanyl)-6,8-dioxabicyclo[3.2.1]octan-3-ol | Formula: | C19 H21 N O3 S | SMILES: | c1ccccc1CNC3C2OC(OC2)C(C3O)Sc4ccccc4 | InChi: | InChI=1S/C19H21NO3S/c21-17-16(20-11-13-7-3-1-4-8-13)15-12-22-19(23-15)18(17)24-14-9-5-2-6-10-14/h1-10,15-21H,11-12H2/t15-,16-,17+,18-,19-/m1/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | (1S,2S,3S,4R,5R)-2-(benzylamino)-4-(phenylsulfanyl)-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
| DDV | Name: | (1S,2S,3S,4R,5R)-2-[(cyclopropylmethyl)amino]-4-(phenylsulfanyl)-6,8-dioxabicyclo[3.2.1]octan-3-ol | Formula: | C16 H21 N O3 S | SMILES: | c1ccccc1SC2C4OC(C(C2O)NCC3CC3)CO4 | InChi: | InChI=1S/C16H21NO3S/c18-14-13(17-8-10-6-7-10)12-9-19-16(20-12)15(14)21-11-4-2-1-3-5-11/h1-5,10,12-18H,6-9H2/t12-,13-,14+,15-,16-/m1/s1 | Definition date: | 2017-10-23 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | (1S,2S,3S,4R,5R)-2-[(cyclopropylmethyl)amino]-4-(phenylsulfanyl)-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
| T91 | Name: | N-[2-(1H-benzimidazol-2-yl)ethyl]-2,2-dimethylpropanamide | Formula: | C14 H19 N3 O | SMILES: | n1c(CCNC(C(C)(C)C)=O)nc2c1cccc2 | InChi: | InChI=1S/C14H19N3O/c1-14(2,3)13(18)15-9-8-12-16-10-6-4-5-7-11(10)17-12/h4-7H,8-9H2,1-3H3,(H,15,18)(H,16,17) | Definition date: | 2020-03-16 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | N-[2-(1H-benzimidazol-2-yl)ethyl]-2,2-dimethylpropanamide |
|
| S3Y | Name: | [(4S)-1-(4-chlorophenyl)-1,2,3-triazolidin-4-yl]methanol | Formula: | C9 H12 Cl N3 O | SMILES: | C(O)C1NNN(C1)c2ccc(cc2)Cl | InChi: | InChI=1S/C9H12ClN3O/c10-7-1-3-9(4-2-7)13-5-8(6-14)11-12-13/h1-4,8,11-12,14H,5-6H2 | Definition date: | 2020-03-04 | Last modified: | 2020-04-17 | Release date: | 2020-04-22 | Identifier: | [(4S)-1-(4-chlorophenyl)-1,2,3-triazolidin-4-yl]methanol |
|